DE60232522D1 - Verfahren zur vorhersage der behandlungsresultate - Google Patents

Verfahren zur vorhersage der behandlungsresultate

Info

Publication number
DE60232522D1
DE60232522D1 DE60232522T DE60232522T DE60232522D1 DE 60232522 D1 DE60232522 D1 DE 60232522D1 DE 60232522 T DE60232522 T DE 60232522T DE 60232522 T DE60232522 T DE 60232522T DE 60232522 D1 DE60232522 D1 DE 60232522D1
Authority
DE
Germany
Prior art keywords
treatment results
predicting treatment
subjects
population
predicting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60232522T
Other languages
English (en)
Inventor
Stephen C Suffin
Hamlin W Emory
Leonard J Brandt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CNS Response Inc
Original Assignee
CNS Response Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CNS Response Inc filed Critical CNS Response Inc
Application granted granted Critical
Publication of DE60232522D1 publication Critical patent/DE60232522D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
    • A61B5/0006—ECG or EEG signals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/369—Electroencephalography [EEG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/369—Electroencephalography [EEG]
    • A61B5/372—Analysis of electroencephalograms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/369—Electroencephalography [EEG]
    • A61B5/386—Accessories or supplementary instruments therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4833—Assessment of subject's compliance to treatment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7253—Details of waveform analysis characterised by using transforms
    • A61B5/7257—Details of waveform analysis characterised by using transforms using Fourier transforms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Neurology (AREA)
  • Physiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Testing, Inspecting, Measuring Of Stereoscopic Televisions And Televisions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
DE60232522T 2001-07-11 2002-07-11 Verfahren zur vorhersage der behandlungsresultate Expired - Lifetime DE60232522D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30462801P 2001-07-11 2001-07-11
PCT/US2002/021976 WO2003005899A2 (en) 2001-07-11 2002-07-11 Electroencepahlography based systems and methods for selecting therapies and predicting outcomes

Publications (1)

Publication Number Publication Date
DE60232522D1 true DE60232522D1 (de) 2009-07-16

Family

ID=23177299

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60232522T Expired - Lifetime DE60232522D1 (de) 2001-07-11 2002-07-11 Verfahren zur vorhersage der behandlungsresultate

Country Status (8)

Country Link
US (5) US7177675B2 (de)
EP (4) EP1414343B1 (de)
AT (1) ATE433163T1 (de)
AU (1) AU2002329590B2 (de)
CA (2) CA2752782A1 (de)
DE (1) DE60232522D1 (de)
ES (1) ES2329452T3 (de)
WO (1) WO2003005899A2 (de)

Families Citing this family (309)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6622036B1 (en) * 2000-02-09 2003-09-16 Cns Response Method for classifying and treating physiologic brain imbalances using quantitative EEG
US20050251061A1 (en) * 2000-11-20 2005-11-10 Schuler Eleanor L Method and system to record, store and transmit waveform signals to regulate body organ function
US7403814B2 (en) * 2001-05-04 2008-07-22 University Of Virginia Patent Foundation Method, apparatus, and computer program product for assessment of attentional impairments
EP1414343B1 (de) * 2001-07-11 2009-06-03 CNS Response, Inc. Verfahren zur vorhersage der behandlungsresultate
US20030171657A1 (en) * 2002-01-22 2003-09-11 Ralph Leonard Selection of optimal medication methodology (SOOMM)
US7065528B2 (en) * 2002-07-24 2006-06-20 Herz Frederick S M Professional referral network
US20040167423A1 (en) * 2002-12-20 2004-08-26 Luana Pillon RXc graph and RXc Z-score graph methods
US6993380B1 (en) * 2003-06-04 2006-01-31 Cleveland Medical Devices, Inc. Quantitative sleep analysis method and system
NZ527142A (en) 2003-07-23 2006-03-31 Douglas Pharmaceuticals Ltd A stable suspension formulation
US10806404B2 (en) * 2004-03-05 2020-10-20 Health Outcomes Sciences, Inc. Systems and methods for utilizing wireless physiological sensors
AU2005223637A1 (en) * 2004-03-18 2005-09-29 University Of Virginia Patent Foundation Method, apparatus, and computer program product for stochastic psycho-physiological assessment of attentional impairments
US7185897B2 (en) * 2004-06-01 2007-03-06 Robert Musselman Thin, quick-mount runner for a snowmobile ski and method
WO2006096192A1 (en) * 2004-06-09 2006-09-14 Honeywell International, Inc. Communications system based on real-time neurophysiological characterization
US20060129324A1 (en) * 2004-12-15 2006-06-15 Biogenesys, Inc. Use of quantitative EEG (QEEG) alone and/or other imaging technology and/or in combination with genomics and/or proteomics and/or biochemical analysis and/or other diagnostic modalities, and CART and/or AI and/or statistical and/or other mathematical analysis methods for improved medical and other diagnosis, psychiatric and other disease treatment, and also for veracity verification and/or lie detection applications.
US8473043B1 (en) * 2004-12-22 2013-06-25 Neuro Wave Systems Inc. Neuro-behavioral test method for screening and evaluating therapy for ADHD and system
JP2008526388A (ja) * 2005-01-12 2008-07-24 アスペクト メディカル システムズ，インク． 精神および神経疾患の治療中の有害事象を予測するためのシステムおよび方法
US8825166B2 (en) 2005-01-21 2014-09-02 John Sasha John Multiple-symptom medical treatment with roving-based neurostimulation
US11389661B2 (en) * 2005-01-21 2022-07-19 Michael Sasha John Programming adjustment for brain network treatment
US7643969B2 (en) 2005-03-04 2010-01-05 Health Outcomes Sciences, Llc Methods and apparatus for providing decision support
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US8547248B2 (en) 2005-09-01 2013-10-01 Proteus Digital Health, Inc. Implantable zero-wire communications system
US20070156453A1 (en) * 2005-10-07 2007-07-05 Brainlab Ag Integrated treatment planning system
US8311622B2 (en) 2005-12-01 2012-11-13 Neba Health LLC Systems and methods for analyzing and assessing depression and other mood disorders using electroencephalographic (EEG) measurements
EP1996076A2 (de) * 2006-03-21 2008-12-03 Eugen Oetringer Vorrichtungen und verfahren zur analyse eines physiologischen zustands eines physiologischen subjekts auf basis einer eigenschaft im zusammenhang mit der arbeitslast
EP2013829A4 (de) 2006-05-02 2010-07-07 Proteus Biomedical Inc Patientenspezifische therapieformen
US8521270B2 (en) * 2006-06-05 2013-08-27 The Regents Of The University Of California Quantitative EEG method to identify individuals at risk for adverse antidepressant effects
KR20090028807A (ko) * 2006-07-06 2009-03-19 리전츠 오브 더 유니버스티 오브 미네소타 시간적 측정치를 이용하는 뇌 패턴의 분석
US20080082359A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of State Of Delaware Computational systems for biomedical data
US20080109484A1 (en) * 2006-09-29 2008-05-08 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082367A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082584A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US7853626B2 (en) * 2006-09-29 2010-12-14 The Invention Science Fund I, Llc Computational systems for biomedical data
US10503872B2 (en) * 2006-09-29 2019-12-10 Gearbox Llc Computational systems for biomedical data
US8122073B2 (en) * 2006-09-29 2012-02-21 The Invention Science Fund I Computational systems for biomedical data
US10546652B2 (en) * 2006-09-29 2020-01-28 Gearbox Llc Computational systems for biomedical data
US20080082364A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US10095836B2 (en) * 2006-09-29 2018-10-09 Gearbox Llc Computational systems for biomedical data
US10068303B2 (en) * 2006-09-29 2018-09-04 Gearbox Llc Computational systems for biomedical data
US20080082307A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US20080082306A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US20080091730A1 (en) * 2006-09-29 2008-04-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082583A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
ATE535057T1 (de) * 2006-10-17 2011-12-15 Proteus Biomedical Inc Niederspannungsoszillator für medizinische einrichtungen
WO2008051992A2 (en) * 2006-10-23 2008-05-02 Lexicor Medical Technology, Llc Systems and methods for analyzing and assessing attention deficit hyperactivity disorder
KR101611240B1 (ko) 2006-10-25 2016-04-11 프로테우스 디지털 헬스, 인코포레이티드 복용 가능한 제어된 활성화 식별자
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
WO2008095183A2 (en) 2007-02-01 2008-08-07 Proteus Biomedical, Inc. Ingestible event marker systems
US8956288B2 (en) 2007-02-14 2015-02-17 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
EP2063771A1 (de) 2007-03-09 2009-06-03 Proteus Biomedical, Inc. Körperintegrierte vorrichtung mit ausfahrbarer antenne
JP5309126B2 (ja) 2007-03-29 2013-10-09 ニューロフォーカス・インコーポレーテッド マーケティング及びエンタテインメントの効率解析を行うシステム、方法、及び、装置
WO2008137581A1 (en) 2007-05-01 2008-11-13 Neurofocus, Inc. Neuro-feedback based stimulus compression device
WO2008137579A1 (en) * 2007-05-01 2008-11-13 Neurofocus, Inc. Neuro-informatics repository system
WO2008141340A1 (en) * 2007-05-16 2008-11-20 Neurofocus, Inc. Audience response measurement and tracking system
US8392253B2 (en) 2007-05-16 2013-03-05 The Nielsen Company (Us), Llc Neuro-physiology and neuro-behavioral based stimulus targeting system
US20090024449A1 (en) * 2007-05-16 2009-01-22 Neurofocus Inc. Habituation analyzer device utilizing central nervous system, autonomic nervous system and effector system measurements
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
US8494905B2 (en) * 2007-06-06 2013-07-23 The Nielsen Company (Us), Llc Audience response analysis using simultaneous electroencephalography (EEG) and functional magnetic resonance imaging (fMRI)
US20090030287A1 (en) * 2007-06-06 2009-01-29 Neurofocus Inc. Incented response assessment at a point of transaction
US20090036755A1 (en) * 2007-07-30 2009-02-05 Neurofocus, Inc. Entity and relationship assessment and extraction using neuro-response measurements
JP5542051B2 (ja) 2007-07-30 2014-07-09 ニューロフォーカス・インコーポレーテッド 神経応答刺激及び刺激属性共鳴推定を行うシステム、方法、及び、装置
AU2008283852A1 (en) * 2007-08-06 2009-02-12 Great Lakes Biosciences, Llc Apparatus and method for remote assessment and therapy management in medical devices via interface systems
DE102007037103B4 (de) * 2007-08-07 2015-12-17 Siemens Aktiengesellschaft Verfahren und Vorrichtung zum bildlichen Darstellen von funktionellen und elektrischen Aktivitäten des Gehirns
KR20100047865A (ko) 2007-08-28 2010-05-10 뉴로포커스, 인크. 소비자 경험 평가 시스템
US8386313B2 (en) 2007-08-28 2013-02-26 The Nielsen Company (Us), Llc Stimulus placement system using subject neuro-response measurements
US8635105B2 (en) * 2007-08-28 2014-01-21 The Nielsen Company (Us), Llc Consumer experience portrayal effectiveness assessment system
US8392255B2 (en) 2007-08-29 2013-03-05 The Nielsen Company (Us), Llc Content based selection and meta tagging of advertisement breaks
US8494610B2 (en) * 2007-09-20 2013-07-23 The Nielsen Company (Us), Llc Analysis of marketing and entertainment effectiveness using magnetoencephalography
US20090083129A1 (en) * 2007-09-20 2009-03-26 Neurofocus, Inc. Personalized content delivery using neuro-response priming data
NO2197534T3 (de) * 2007-09-25 2018-08-04
PT2192946T (pt) 2007-09-25 2022-11-17 Otsuka Pharma Co Ltd Dispositivo no corpo com amplificação de sinal dipolo virtual
AU2008310576B2 (en) * 2007-10-12 2014-01-23 Patientslikeme, Inc. Personalized management and comparison of medical condition and outcome based on profiles of community of patients
US7574254B2 (en) * 2007-11-13 2009-08-11 Wavesynch Technologies, Inc. Method for monitoring attentiveness and productivity in a subject
US20100069775A1 (en) * 2007-11-13 2010-03-18 Michael Milgramm EEG-Related Methods
WO2009070773A1 (en) 2007-11-27 2009-06-04 Proteus Biomedical, Inc. Transbody communication systems employing communication channels
US20100286549A1 (en) * 2007-12-18 2010-11-11 New York University System and Method for Assessing Efficacy of Therapeutic Agents
US20110160608A1 (en) * 2007-12-19 2011-06-30 Cerephex Corporation Brain-related chronic pain disorder diagnosis and assessment method
EP2245568A4 (de) 2008-02-20 2012-12-05 Univ Mcmaster Expertensystem zur bestimmung der reaktion von patienten auf eine behandlung
ES2636844T3 (es) 2008-03-05 2017-10-09 Proteus Biomedical, Inc. Sistemas y marcadores de eventos ingeribles de comunicación multimodo, y métodos para usarlos
US8626264B1 (en) * 2008-04-09 2014-01-07 James T. Beran Obtaining information about brain activity
US8606592B2 (en) * 2008-04-24 2013-12-10 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US20090271009A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Combination treatment modification methods and systems
US9064036B2 (en) * 2008-04-24 2015-06-23 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US20100022820A1 (en) * 2008-04-24 2010-01-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational system and method for memory modification
US20090270694A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for monitoring and modifying a combination treatment
US20100004762A1 (en) * 2008-04-24 2010-01-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational system and method for memory modification
US20100041958A1 (en) * 2008-04-24 2010-02-18 Searete Llc Computational system and method for memory modification
US20090312668A1 (en) * 2008-04-24 2009-12-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational system and method for memory modification
US9026369B2 (en) * 2008-04-24 2015-05-05 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US20090271122A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for monitoring and modifying a combination treatment
US20100042578A1 (en) * 2008-04-24 2010-02-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational system and method for memory modification
US8930208B2 (en) 2008-04-24 2015-01-06 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US9239906B2 (en) * 2008-04-24 2016-01-19 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US20100063368A1 (en) * 2008-04-24 2010-03-11 Searete Llc, A Limited Liability Corporation Computational system and method for memory modification
US20090269329A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Combination Therapeutic products and systems
US20100015583A1 (en) * 2008-04-24 2010-01-21 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational System and method for memory modification
US20090271375A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Combination treatment selection methods and systems
US9449150B2 (en) * 2008-04-24 2016-09-20 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US20100280332A1 (en) * 2008-04-24 2010-11-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for monitoring bioactive agent use
US20090271347A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for monitoring bioactive agent use
US20100125561A1 (en) * 2008-04-24 2010-05-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational system and method for memory modification
US20090270688A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting a combination treatment
US20100030089A1 (en) * 2008-04-24 2010-02-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for monitoring and modifying a combination treatment
US20100076249A1 (en) * 2008-04-24 2010-03-25 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational system and method for memory modification
US8615407B2 (en) 2008-04-24 2013-12-24 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US7974787B2 (en) * 2008-04-24 2011-07-05 The Invention Science Fund I, Llc Combination treatment alteration methods and systems
US20100081861A1 (en) * 2008-04-24 2010-04-01 Searete Llc Computational System and Method for Memory Modification
US9662391B2 (en) * 2008-04-24 2017-05-30 The Invention Science Fund I Llc Side effect ameliorating combination therapeutic products and systems
US9560967B2 (en) * 2008-04-24 2017-02-07 The Invention Science Fund I Llc Systems and apparatus for measuring a bioactive agent effect
US20100069724A1 (en) * 2008-04-24 2010-03-18 Searete Llc Computational system and method for memory modification
US9282927B2 (en) 2008-04-24 2016-03-15 Invention Science Fund I, Llc Methods and systems for modifying bioactive agent use
US20100100036A1 (en) * 2008-04-24 2010-04-22 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational System and Method for Memory Modification
US8682687B2 (en) * 2008-04-24 2014-03-25 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US20100041964A1 (en) * 2008-04-24 2010-02-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for monitoring and modifying a combination treatment
US20100130811A1 (en) * 2008-04-24 2010-05-27 Searete Llc Computational system and method for memory modification
US9649469B2 (en) * 2008-04-24 2017-05-16 The Invention Science Fund I Llc Methods and systems for presenting a combination treatment
US20100017001A1 (en) * 2008-04-24 2010-01-21 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational system and method for memory modification
US8876688B2 (en) * 2008-04-24 2014-11-04 The Invention Science Fund I, Llc Combination treatment modification methods and systems
US20100081860A1 (en) * 2008-04-24 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational System and Method for Memory Modification
US20090270687A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for modifying bioactive agent use
US20090312595A1 (en) * 2008-04-24 2009-12-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware System and method for memory modification
US20090312663A1 (en) * 2008-06-13 2009-12-17 New York University System and Method for Neurometric Analysis
US20090326339A1 (en) * 2008-06-26 2009-12-31 Microsoft Corporation Connected healthcare devices with real-time and proactive capture and relay of contextual information
EP3427660A1 (de) 2008-07-08 2019-01-16 Proteus Digital Health, Inc. Datengrundlage für einnehmbare ereignismarker
US20100017226A1 (en) * 2008-07-18 2010-01-21 Siemens Medical Solutions Usa, Inc. Medical workflow oncology task assistance
US20110167025A1 (en) * 2008-07-24 2011-07-07 Kourosh Danai Systems and methods for parameter adaptation
US8712927B2 (en) * 2008-07-24 2014-04-29 University Of Massachusetts Systems and methods for parameter adaptation
WO2010019778A2 (en) 2008-08-13 2010-02-18 Proteus Biomedical, Inc. Ingestible circuitry
US8926490B2 (en) * 2008-09-24 2015-01-06 Neosync, Inc. Systems and methods for depression treatment using neuro-EEG synchronization therapy
KR101192690B1 (ko) * 2008-11-13 2012-10-19 프로테우스 디지털 헬스, 인코포레이티드 섭취 가능한 치료 활성화 시스템, 치료 장치 및 방법
US20100145215A1 (en) * 2008-12-09 2010-06-10 Neurofocus, Inc. Brain pattern analyzer using neuro-response data
EP2358270A4 (de) * 2008-12-11 2014-08-13 Proteus Digital Health Inc Evaluierung von magen-darm-funktionen mithilfe tragbarer elektroviszerographiesysteme und verfahren zu ihrer verwendung
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
TWI503101B (zh) 2008-12-15 2015-10-11 Proteus Digital Health Inc 與身體有關的接收器及其方法
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
CN102341031A (zh) 2009-01-06 2012-02-01 普罗秋斯生物医学公司 摄取相关的生物反馈和个人化医学治疗方法和系统
KR20110104079A (ko) 2009-01-06 2011-09-21 프로테우스 바이오메디컬, 인코포레이티드 약제학적 투여량 전달 시스템
US9357240B2 (en) * 2009-01-21 2016-05-31 The Nielsen Company (Us), Llc Methods and apparatus for providing alternate media for video decoders
US8464288B2 (en) * 2009-01-21 2013-06-11 The Nielsen Company (Us), Llc Methods and apparatus for providing personalized media in video
US8270814B2 (en) * 2009-01-21 2012-09-18 The Nielsen Company (Us), Llc Methods and apparatus for providing video with embedded media
US20100249538A1 (en) * 2009-03-24 2010-09-30 Neurofocus, Inc. Presentation measure using neurographics
US20100250325A1 (en) 2009-03-24 2010-09-30 Neurofocus, Inc. Neurological profiles for market matching and stimulus presentation
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US20100249636A1 (en) * 2009-03-27 2010-09-30 Neurofocus, Inc. Personalized stimulus placement in video games
GB0906029D0 (en) * 2009-04-07 2009-05-20 Nat Univ Ireland Cork A method of analysing an electroencephalogram (EEG) signal
NZ619375A (en) 2009-04-28 2015-03-27 Proteus Digital Health Inc Highly reliable ingestible event markers and methods for using the same
AU2010242036A1 (en) 2009-04-30 2011-11-03 Patientslikeme, Inc. Systems and methods for encouragement of data submission in online communities
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US20100292545A1 (en) * 2009-05-14 2010-11-18 Advanced Brain Monitoring, Inc. Interactive psychophysiological profiler method and system
US20120165696A1 (en) * 2009-06-03 2012-06-28 Martijn Wilco Arns Method for assessing the susceptibility of a human individual suffering from a psychiatric or neurological disorder to neuromodulation treatment
WO2011017466A1 (en) 2009-08-06 2011-02-10 Neosync, Inc. Systems and methods for modulating the electrical activity of a brain using neuro-eeg synchronization therapy
US20110046502A1 (en) * 2009-08-20 2011-02-24 Neurofocus, Inc. Distributed neuro-response data collection and analysis
US8655437B2 (en) 2009-08-21 2014-02-18 The Nielsen Company (Us), Llc Analysis of the mirror neuron system for evaluation of stimulus
EP2467707A4 (de) 2009-08-21 2014-12-17 Proteus Digital Health Inc Vorrichtung und verfahren zur messung biologischer parameter
US10987015B2 (en) * 2009-08-24 2021-04-27 Nielsen Consumer Llc Dry electrodes for electroencephalography
US20110077503A1 (en) * 2009-08-25 2011-03-31 Medical University Of South Carolina Automatic MRI Quantification of Structural Body Abnormalities
RU2558459C2 (ru) * 2009-08-25 2015-08-10 АРГУС НЬЮРООПТИКС, ЭлЭлСи Системы и способы для стимуляции нейрональной активности
US8428738B2 (en) * 2009-08-26 2013-04-23 Andrew D. Valencia Coupled neuraxial mesoscopic desynchronization electrostimulation therapy (cNMDET) method
AU2010286595A1 (en) * 2009-08-28 2012-02-23 NEBA Health, LLC. Systems and methods to identify a subgroup of ADHD at higher risk for complicating conditions
US8756657B2 (en) * 2009-09-29 2014-06-17 Ebay Inc. Mobile or user device authentication and tracking
US20110106750A1 (en) 2009-10-29 2011-05-05 Neurofocus, Inc. Generating ratings predictions using neuro-response data
US8209224B2 (en) * 2009-10-29 2012-06-26 The Nielsen Company (Us), Llc Intracluster content management using neuro-response priming data
US9560984B2 (en) 2009-10-29 2017-02-07 The Nielsen Company (Us), Llc Analysis of controlled and automatic attention for introduction of stimulus material
TWI517050B (zh) 2009-11-04 2016-01-11 普羅托斯數位健康公司 供應鏈管理之系統
US20110112426A1 (en) * 2009-11-10 2011-05-12 Brainscope Company, Inc. Brain Activity as a Marker of Disease
EP2498857B1 (de) 2009-11-12 2020-04-29 Neosync, INC. Systeme und verfahren für eine neuro-eeg-synchronisation
US8335715B2 (en) * 2009-11-19 2012-12-18 The Nielsen Company (Us), Llc. Advertisement exchange using neuro-response data
US8335716B2 (en) * 2009-11-19 2012-12-18 The Nielsen Company (Us), Llc. Multimedia advertisement exchange
US8315962B1 (en) * 2009-11-25 2012-11-20 Science Applications International Corporation System and method for multiclass discrimination of neural response data
UA109424C2 (uk) 2009-12-02 2015-08-25 Фармацевтичний продукт, фармацевтична таблетка з електронним маркером і спосіб виготовлення фармацевтичної таблетки
US8579812B2 (en) * 2009-12-15 2013-11-12 Brainscope Company, Inc. System and methods for management of disease over time
US8577451B2 (en) * 2009-12-16 2013-11-05 Brainscope Company, Inc. System and methods for neurologic monitoring and improving classification and treatment of neurologic states
US8645299B2 (en) * 2009-12-31 2014-02-04 Mckesson Financial Holdings Method, apparatus and computer program product for context based tagging of data
JP5841951B2 (ja) 2010-02-01 2016-01-13 プロテウス デジタル ヘルス， インコーポレイテッド データ収集システム
US20110237971A1 (en) * 2010-03-25 2011-09-29 Neurofocus, Inc. Discrete choice modeling using neuro-response data
WO2011127252A2 (en) 2010-04-07 2011-10-13 Proteus Biomedical, Inc. Miniature ingestible device
WO2011133548A2 (en) 2010-04-19 2011-10-27 Innerscope Research, Inc. Short imagery task (sit) research method
US8655428B2 (en) 2010-05-12 2014-02-18 The Nielsen Company (Us), Llc Neuro-response data synchronization
TWI557672B (zh) 2010-05-19 2016-11-11 波提亞斯數位康健公司 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置
US8392250B2 (en) 2010-08-09 2013-03-05 The Nielsen Company (Us), Llc Neuro-response evaluated stimulus in virtual reality environments
US8392251B2 (en) 2010-08-09 2013-03-05 The Nielsen Company (Us), Llc Location aware presentation of stimulus material
US8396744B2 (en) 2010-08-25 2013-03-12 The Nielsen Company (Us), Llc Effective virtual reality environments for presentation of marketing materials
WO2012028834A1 (en) * 2010-09-01 2012-03-08 Marcel Petrus Maria Bartels Use of bupropion in treating sexual dysfunction
EP2425769A1 (de) * 2010-09-03 2012-03-07 Sensodetect AB System und Verfahren zur Bestimmung der Hirnstammreaktionszustandsentwicklung
US8892184B2 (en) 2010-10-18 2014-11-18 Siemens Medical Solutions Usa, Inc. Systems and methods for reducing interference in a dual modality imaging system
CN103210415A (zh) * 2010-10-29 2013-07-17 Sk电信有限公司 用于诊断学习能力的设备和方法
EP2642983A4 (de) 2010-11-22 2014-03-12 Proteus Digital Health Inc Einnehmbare vorrichtung mit einem pharmazeutischen produkt
US9439599B2 (en) 2011-03-11 2016-09-13 Proteus Digital Health, Inc. Wearable personal body associated device with various physical configurations
WO2012155185A1 (en) 2011-05-13 2012-11-22 National Ict Australia Ltd Method and apparatus for measurement of neural response
WO2012155189A1 (en) 2011-05-13 2012-11-22 National Ict Australia Ltd Method and apparatus for estimating neural recruitment - f
CA2835486C (en) 2011-05-13 2022-07-19 Saluda Medical Pty Limited Method and apparatus for measurement of neural response - a
US9872990B2 (en) 2011-05-13 2018-01-23 Saluda Medical Pty Limited Method and apparatus for application of a neural stimulus
RU2459208C1 (ru) * 2011-05-27 2012-08-20 Учреждение Российской Академии Медицинских Наук Научно-Исследовательский Институт Психического Здоровья Сибирского Отделения Российской Академии Медицинских Наук Способ прогнозирования эффективности терапии ладастеном органических астенических расстройств
US9040082B2 (en) 2011-06-24 2015-05-26 K-Pax Pharmaceuticals, Inc. Compositions and methods for treatment of chronic fatigue
US20130172774A1 (en) 2011-07-01 2013-07-04 Neuropace, Inc. Systems and Methods for Assessing the Effectiveness of a Therapy Including a Drug Regimen Using an Implantable Medical Device
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
MX340001B (es) 2011-07-21 2016-06-20 Proteus Digital Health Inc Dispositivo, sistema y método de comunicación móvil.
CA2842359A1 (en) 2011-08-01 2013-02-07 Denovo Sciences Cell capture system and method of use
US20130035579A1 (en) 2011-08-02 2013-02-07 Tan Le Methods for modeling neurological development and diagnosing a neurological impairment of a patient
US9772270B2 (en) 2011-08-16 2017-09-26 Elwha Llc Devices and methods for recording information on a subject's body
US9443061B2 (en) 2011-08-16 2016-09-13 Elwha Llc Devices and methods for recording information on a subject's body
US9286615B2 (en) * 2011-08-16 2016-03-15 Elwha Llc Devices and methods for recording information on a subject's body
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US9649502B2 (en) 2011-11-14 2017-05-16 Neosync, Inc. Devices and methods of low frequency magnetic stimulation therapy
US20150011864A1 (en) * 2012-01-30 2015-01-08 New York University Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease
US9451303B2 (en) 2012-02-27 2016-09-20 The Nielsen Company (Us), Llc Method and system for gathering and computing an audience's neurologically-based reactions in a distributed framework involving remote storage and computing
US9292858B2 (en) 2012-02-27 2016-03-22 The Nielsen Company (Us), Llc Data collection system for aggregating biologically based measures in asynchronous geographically distributed public environments
US9569986B2 (en) 2012-02-27 2017-02-14 The Nielsen Company (Us), Llc System and method for gathering and analyzing biometric user feedback for use in social media and advertising applications
JP6123167B2 (ja) 2012-04-05 2017-05-10 ソニー株式会社 脳波解析装置及び脳波解析プログラム
US9763592B2 (en) 2012-05-25 2017-09-19 Emotiv, Inc. System and method for instructing a behavior change in a user
US9622660B2 (en) 2012-05-25 2017-04-18 Emotiv Lifesciences Inc. System and method for enabling collaborative analysis of a biosignal
US9867548B2 (en) 2012-05-25 2018-01-16 Emotiv, Inc. System and method for providing and aggregating biosignals and action data
US9814426B2 (en) 2012-06-14 2017-11-14 Medibotics Llc Mobile wearable electromagnetic brain activity monitor
JP2015534539A (ja) 2012-07-23 2015-12-03 プロテウス デジタル ヘルス， インコーポレイテッド 摂取可能構成要素を備える摂取可能事象マーカーを製造するための技法
WO2014017970A2 (en) * 2012-07-24 2014-01-30 Scientificmed Sweden Ab Improved clinical effect of pharmaceutical products using communication tool and life-style factors
US8989835B2 (en) 2012-08-17 2015-03-24 The Nielsen Company (Us), Llc Systems and methods to gather and analyze electroencephalographic data
JP5869736B2 (ja) 2012-10-18 2016-02-24 プロテウス デジタル ヘルス， インコーポレイテッド 通信デバイス用の電源において電力消失およびブロードキャスト電力を適応的に最適化するための装置、システム、および方法
EP2908904B1 (de) 2012-11-06 2020-09-23 Saluda Medical Pty Limited System zur steuerung der elektrischen bedingungen eines gewebes
WO2014107564A1 (en) * 2013-01-03 2014-07-10 Wake Forest University Health Sciences Methods and devices for predicting and/or detecting seizures
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US9532716B2 (en) * 2013-03-04 2017-01-03 Hello Inc. Systems using lifestyle database analysis to provide feedback
US9357922B2 (en) * 2013-03-04 2016-06-07 Hello Inc. User or patient monitoring systems with one or more analysis tools
US9530089B2 (en) 2013-03-04 2016-12-27 Hello Inc. Wearable device with overlapping ends coupled by magnets of a selected width, length and depth
US9526422B2 (en) 2013-03-04 2016-12-27 Hello Inc. System for monitoring individuals with a monitoring device, telemetry system, activity manager and a feedback system
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9320450B2 (en) 2013-03-14 2016-04-26 The Nielsen Company (Us), Llc Methods and apparatus to gather and analyze electroencephalographic data
WO2014151929A1 (en) 2013-03-15 2014-09-25 Proteus Digital Health, Inc. Personal authentication apparatus system and method
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
EP2967354A4 (de) * 2013-03-15 2017-05-31 Adam J. Simon Multimodale pharmakodiagnostische beurteilung der hirngesundheit
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes
KR20160055103A (ko) 2013-03-15 2016-05-17 아담 제이 사이먼 뇌 건강의 다중-모드 생리적 자극 및 평가를 위한 시스템 및 시그너처
WO2014144738A1 (en) 2013-03-15 2014-09-18 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
EP3027110A4 (de) 2013-07-30 2017-06-28 Emotiv Lifesciences, Inc. Am körper tragbares system zum nachweis und zur messung von biosignalen
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
CA2965941C (en) 2013-09-20 2020-01-28 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
WO2015044722A1 (en) 2013-09-24 2015-04-02 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11172864B2 (en) 2013-11-15 2021-11-16 Closed Loop Medical Pty Ltd Monitoring brain neural potentials
JP6671021B2 (ja) 2013-11-22 2020-03-25 サルーダ・メディカル・ピーティーワイ・リミテッド 神経測定において神経反応を検出するための方法およびデバイス
US11568982B1 (en) 2014-02-17 2023-01-31 Health at Scale Corporation System to improve the logistics of clinical care by selectively matching patients to providers
US9622702B2 (en) 2014-04-03 2017-04-18 The Nielsen Company (Us), Llc Methods and apparatus to gather and analyze electroencephalographic data
US11114204B1 (en) 2014-04-04 2021-09-07 Predictive Modeling, Inc. System to determine inpatient or outpatient care and inform decisions about patient care
ES2801348T3 (es) 2014-05-05 2021-01-11 Saluda Medical Pty Ltd Medición neurológica mejorada
US10588576B2 (en) 2014-08-15 2020-03-17 Neosync, Inc. Methods and device for determining a valid intrinsic frequency
DE102014014354A1 (de) * 2014-09-27 2016-03-31 Lars Holger Hermann Methylphenidat oder ein physiologisch annehmbares Salz desselben zur Verwendung in der Behandlung von Anorexia nervosa
US20160092642A1 (en) * 2014-09-29 2016-03-31 Mckesson Corporation Determining Orphan Drug Eligibility for Reduced Pricing
US20160070880A1 (en) * 2014-10-09 2016-03-10 Iqg Llc Dba Iqgateway Method and system for predicting continous cardiac output (cco) of a patient based on physiological data
EP4285985A3 (de) 2014-12-11 2024-01-17 Saluda Medical Pty Ltd Verfahren und vorrichtung zur rückkopplungssteuerung der nervenstimulation
US10820864B2 (en) * 2015-03-02 2020-11-03 Valencia Technologies Corporation Methods and systems for predicting patient responsiveness to subcutaneous neuromodulation therapy as a treatment for hypertension
US10108264B2 (en) 2015-03-02 2018-10-23 Emotiv, Inc. System and method for embedded cognitive state metric system
AU2016245335B2 (en) 2015-04-09 2020-11-19 Saluda Medical Pty Ltd Electrode to nerve distance estimation
US9936250B2 (en) 2015-05-19 2018-04-03 The Nielsen Company (Us), Llc Methods and apparatus to adjust content presented to an individual
EP3302692B1 (de) 2015-05-31 2024-07-24 Closed Loop Medical Pty Ltd Elektrodenbefestigung für hirnneurostimulator
WO2016201500A1 (en) 2015-06-15 2016-12-22 Medibio Limited Method and system for monitoring stress conditions
EP3307165A4 (de) 2015-06-15 2019-01-02 Medibio Limited Verfahren und system zur beurteilung des mentalen zustands
DE102015109853A1 (de) * 2015-06-19 2016-12-22 Nclogics Ag Assistenz- und Entscheidungssystem und Verfahren zur Auswertung von Elektroenzephalogrammen
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US20170032106A1 (en) * 2015-07-31 2017-02-02 Astellas Pharma Europe Ltd. System and Method for Analyzing Adverse Event Data
WO2017027709A1 (en) 2015-08-11 2017-02-16 Cognoa, Inc. Methods and apparatus to determine developmental progress with artificial intelligence and user input
US10709371B2 (en) * 2015-09-09 2020-07-14 WellBrain, Inc. System and methods for serving a custom meditation program to a patient
US11972336B2 (en) 2015-12-18 2024-04-30 Cognoa, Inc. Machine learning platform and system for data analysis
US11020035B2 (en) 2016-02-01 2021-06-01 Epitel, Inc. Self-contained EEG recording system
CA3019701A1 (en) 2016-04-05 2017-10-12 Saluda Medical Pty Ltd Improved feedback control of neuromodulation
JP6785446B2 (ja) * 2016-04-14 2020-11-18 パナソニックＩｐマネジメント株式会社 生体信号計測システム
WO2017205733A1 (en) * 2016-05-27 2017-11-30 Parexel International Corporation Decision support system for cns drug development
EP3474747A4 (de) 2016-06-24 2020-01-22 Saluda Medical Pty Ltd Nervenstimulation für reduziertes artefakt
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US20190180859A1 (en) * 2016-08-02 2019-06-13 Beyond Verbal Communication Ltd. System and method for creating an electronic database using voice intonation analysis score correlating to human affective states
WO2018073895A1 (ja) * 2016-10-18 2018-04-26 富士通株式会社 類似症例検索プログラム、類似症例検索装置および類似症例検索方法
TWI735689B (zh) 2016-10-26 2021-08-11 日商大塚製藥股份有限公司 製造含有可攝食性事件標記之膠囊之方法
JP7182554B2 (ja) * 2016-11-14 2022-12-02 コグノア，インク． 発達に係る疾病を評価し、およびカバー率と信頼度に対する制御を提供する方法および装置
US11246520B2 (en) 2016-12-12 2022-02-15 Emory University Using heartrate information to classify PTSD
CN110325112A (zh) * 2017-01-04 2019-10-11 斯托瑞阿普股份有限公司 使用虚拟现实疗法修改生物测定活动的系统和方法
JP1602547S (de) 2017-01-17 2018-04-23
EP3580700A4 (de) 2017-02-09 2020-11-18 Cognoa, Inc. Plattform und system für digitale personalisierte medizin
WO2018217655A1 (en) 2017-05-22 2018-11-29 Genetesis Llc Machine differentiation of abnormalities in bioelectromagnetic fields
EP3420898A1 (de) 2017-06-28 2019-01-02 Koninklijke Philips N.V. Beurteilung des deliriums bei einer person
US11311724B2 (en) * 2017-07-28 2022-04-26 The Regents Of The University Of California Transcutaneous and transcranial nerve stimulation
US10863912B2 (en) 2017-08-24 2020-12-15 Myneurva Holdings, Inc. System and method for analyzing electroencephalogram signals
US20190076046A1 (en) * 2017-09-13 2019-03-14 Stimscience Inc. Systems, methods, and devices for closed loop control
US11723579B2 (en) 2017-09-19 2023-08-15 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement
US10747317B2 (en) 2017-10-18 2020-08-18 Biofli Technologies, Inc. Systematic bilateral situational awareness tracking apparatus and method
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
CN111670002A (zh) * 2017-12-05 2020-09-15 神经索引公司 麻醉管理的系统及方法
US11478603B2 (en) 2017-12-31 2022-10-25 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
JP6950097B2 (ja) * 2018-01-26 2021-10-13 株式会社日立ハイテクソリューションズ 医療成果を達成するための制御デバイス
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
CN112334184A (zh) 2018-04-27 2021-02-05 萨鲁达医疗有限公司 混合神经的神经刺激
US11452839B2 (en) 2018-09-14 2022-09-27 Neuroenhancement Lab, LLC System and method of improving sleep
CN113383395A (zh) * 2018-10-22 2021-09-10 皇家飞利浦有限公司 用于睡眠障碍识别的决策支持软件系统
WO2020085935A1 (ru) * 2018-10-24 2020-04-30 Общество С Ограниченнной Ответственностью "Май Брэйн" Способ для автоматизированного восстановления функций головного мозга
US11894139B1 (en) 2018-12-03 2024-02-06 Patientslikeme Llc Disease spectrum classification
KR102643554B1 (ko) 2019-03-22 2024-03-04 코그노아, 인크. 개인 맞춤식 디지털 치료 방법 및 디바이스
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep
US11581093B2 (en) * 2019-09-19 2023-02-14 Merative Us L.P. Automatic detection of mental health condition and patient classification using machine learning
US12014835B2 (en) * 2020-02-19 2024-06-18 Vanderbilt University Methods for evaluating therapeutic benefit of combination therapies
US20210307672A1 (en) 2020-04-05 2021-10-07 Epitel, Inc. Eeg recording and analysis
US11610679B1 (en) 2020-04-20 2023-03-21 Health at Scale Corporation Prediction and prevention of medical events using machine-learning algorithms
US12094582B1 (en) 2020-08-11 2024-09-17 Health at Scale Corporation Intelligent healthcare data fabric system
US12080428B1 (en) 2020-09-10 2024-09-03 Health at Scale Corporation Machine intelligence-based prioritization of non-emergent procedures and visits
US20220310263A1 (en) * 2021-03-25 2022-09-29 Larry B. Gelman Treatment protocol for assessing and managing pain, based on the patient's risk of opioid misuse, abuse, and/or addiction, and method of use
WO2023239621A1 (en) * 2022-06-05 2023-12-14 Branelie Health, Inc. Healthcare system for and methods of managing brain injury or concussion
US12070318B2 (en) 2022-10-19 2024-08-27 Epitel, Inc. Systems and methods for electroencephalogram monitoring

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4128641A (en) * 1975-07-31 1978-12-05 Hzi Research Center Inc. Tetracyclic psychotropic drug
US4201224A (en) 1978-12-29 1980-05-06 Roy John E Electroencephalographic method and system for the quantitative description of patient brain states
US5083571A (en) * 1988-04-18 1992-01-28 New York University Use of brain electrophysiological quantitative data to classify and subtype an individual into diagnostic categories by discriminant and cluster analysis
US5357976A (en) 1989-10-30 1994-10-25 Genquan Feng Method of and arrangement for diagnosing brain disease
US5176145A (en) 1990-04-25 1993-01-05 Ryback Ralph S Method for diagnosing a patient to determine whether the patient suffers from limbic system dysrhythmia
US5730146A (en) * 1991-08-01 1998-03-24 Itil; Turan M. Transmitting, analyzing and reporting EEG data
WO1995018565A1 (en) 1991-09-26 1995-07-13 Sam Technology, Inc. Non-invasive neurocognitive testing method and system
US5230346A (en) * 1992-02-04 1993-07-27 The Regents Of The University Of California Diagnosing brain conditions by quantitative electroencephalography
CA2142906A1 (en) * 1992-08-21 1994-03-03 Peter L. Brill Method and apparatus for measuring psychotherapy outcomes
US5267570A (en) * 1992-12-30 1993-12-07 Preston Myra S Method of diagnosing and treating chronic fatigue syndrome
US5445162A (en) 1993-08-27 1995-08-29 Beth Israel Hospital Association Apparatus and method for recording an electroencephalogram during magnetic resonance imaging
US5523323A (en) * 1993-09-14 1996-06-04 Maccecchini; Maria-Luisa Use of partial agonists of the NMDA receptor to reduce opiate induced tolerance and dependence
US6067467A (en) * 1994-02-07 2000-05-23 New York University EEG operative and post-operative patient monitoring method
JP3310498B2 (ja) 1994-09-02 2002-08-05 独立行政法人産業技術総合研究所 生体情報解析装置および生体情報解析方法
US5737539A (en) * 1994-10-28 1998-04-07 Advanced Health Med-E-Systems Corp. Prescription creation system
US5632276A (en) * 1995-01-27 1997-05-27 Eidelberg; David Markers for use in screening patients for nervous system dysfunction and a method and apparatus for using same
GB9511964D0 (en) * 1995-06-13 1995-08-09 Rdm Consultants Limited Monitoring an EEG
US5611350A (en) * 1996-02-08 1997-03-18 John; Michael S. Method and apparatus for facilitating recovery of patients in deep coma
US5860917A (en) * 1997-01-15 1999-01-19 Chiron Corporation Method and apparatus for predicting therapeutic outcomes
US5871517A (en) 1997-01-15 1999-02-16 Somatics, Inc. Convulsive therapy apparatus to stimulate and monitor the extent of therapeutic value of the treatment
US5842213A (en) * 1997-01-28 1998-11-24 Odom; Paul S. Method for modeling, storing, and transferring data in neutral form
US6063028A (en) * 1997-03-20 2000-05-16 Luciano; Joanne Sylvia Automated treatment selection method
US6622036B1 (en) * 2000-02-09 2003-09-16 Cns Response Method for classifying and treating physiologic brain imbalances using quantitative EEG
UA57107C2 (uk) * 1997-09-23 2003-06-16 Елі Ліллі Енд Компані Спосіб лікування розладу поведінки
US6016449A (en) * 1997-10-27 2000-01-18 Neuropace, Inc. System for treatment of neurological disorders
KR100281650B1 (ko) 1997-11-13 2001-02-15 정선종 긍정/부정 감성 상태 판별을 위한 뇌파 분석 방법
US6016444A (en) * 1997-12-10 2000-01-18 New York University Automatic control of anesthesia using quantitative EEG
US6195576B1 (en) * 1998-03-09 2001-02-27 New York University Quantitative magnetoencephalogram system and method
AUPP354798A0 (en) * 1998-05-15 1998-06-11 Swinburne Limited Decentralised patient management system
US6226408B1 (en) * 1999-01-29 2001-05-01 Hnc Software, Inc. Unsupervised identification of nonlinear data cluster in multidimensional data
US6598084B1 (en) * 1999-02-16 2003-07-22 Sony Corporation Methods and apparatus for processing, transmitting, and receiving data from a modular electronic medical device
US7418399B2 (en) * 1999-03-10 2008-08-26 Illinois Institute Of Technology Methods and kits for managing diagnosis and therapeutics of bacterial infections
US6581038B1 (en) * 1999-03-15 2003-06-17 Nexcura, Inc. Automated profiler system for providing medical information to patients
US6463321B2 (en) * 1999-08-10 2002-10-08 Thuris Corporation Method and computer program product for assessing neurological conditions and treatments using evoked response potentials
US6223074B1 (en) * 1999-08-10 2001-04-24 Thuris Corporation Method and computer program product for assessing neurological conditions and treatments using evoked response potentials
US6333357B1 (en) * 1999-11-05 2001-12-25 Be Able, Llc Behavior chemotherapy
US6434419B1 (en) * 2000-06-26 2002-08-13 Sam Technology, Inc. Neurocognitive ability EEG measurement method and system
US6711564B2 (en) * 2001-02-15 2004-03-23 Apteryx, Inc. System and method for opening and activating applications, windows or data sets based on search criteria
US20060252761A1 (en) * 2001-03-29 2006-11-09 Michael Davis Augmentation of extinction via administration of sub-antimicrobial doses of D-cycloserine
EP1414343B1 (de) * 2001-07-11 2009-06-03 CNS Response, Inc. Verfahren zur vorhersage der behandlungsresultate

Also Published As

Publication number Publication date
EP1414343A2 (de) 2004-05-06
CA2752782A1 (en) 2003-01-23
AU2002329590B2 (en) 2006-10-19
US20100143256A1 (en) 2010-06-10
EP2159723A1 (de) 2010-03-03
EP1414343A4 (de) 2005-05-25
US20090137923A1 (en) 2009-05-28
WO2003005899A2 (en) 2003-01-23
US7489964B2 (en) 2009-02-10
US7962204B2 (en) 2011-06-14
US20030135128A1 (en) 2003-07-17
WO2003005899A3 (en) 2003-04-24
US7177675B2 (en) 2007-02-13
US20090157662A1 (en) 2009-06-18
ES2329452T3 (es) 2009-11-26
US8224433B2 (en) 2012-07-17
EP1414343B1 (de) 2009-06-03
EP2323056A1 (de) 2011-05-18
US20080125669A1 (en) 2008-05-29
EP2275959A3 (de) 2011-04-06
EP2275959A2 (de) 2011-01-19
CA2452883A1 (en) 2003-01-23
ATE433163T1 (de) 2009-06-15
CA2452883C (en) 2012-01-03

Similar Documents

Publication Publication Date Title
DE60232522D1 (de) Verfahren zur vorhersage der behandlungsresultate
ATE526041T1 (de) Verfahren zur hemmung okularer vorgänge
DE60233485D1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
ATE437184T1 (de) Varianten der fc-region
ATE386970T1 (de) Zugriffs- und benutzungsmethoden für webseiten
DE69738362D1 (de) Methode zur Nivellierungsüberwachung mit verbesserter Genauigkeit für eine Aufzugskabine
ATE407221T1 (de) Diagnostika für fragile plaque störung
DE60016178D1 (de) Verfahren zur diagnose und zur charakterisierung von schlaganfall
EA200300027A1 (ru) Способ лечения сердечно-сосудистых заболеваний
ATA1112001A (de) Verfahren zur tragekontrolle von regulierungen
DE50207514D1 (de) Verfahren zu beeinflussung des wankverhaltens von kraftfahrzeugen
DE50213709D1 (de) Verfahren zur bereitstellung von zielführungshinweisen
CY1110138T1 (el) Προσδιορισμος υψηλης διεκπεραιωτικοτητας της δραστικοτητας lp-pla2
DK0948604T3 (da) Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet
BR9804676A (pt) Processo para o teste de um dispositivo de embreagem automatizado.
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
WO2002006534A3 (en) Method of diagnosing pulmonary hypertension
ATE450604T1 (de) Gsk3-polypeptide
ATE306659T1 (de) Küvette für ein lesegerät zur bestimmung von substanzen mittels der evaneszenzfeldmethode
EA200200435A1 (ru) Анализ лептина
DE60216570D1 (de) Verfahren zum nachweis von alzheimer-krankheit
DE60208415D1 (de) Verfahren zur optimierung von testdaten
BR0210138B1 (pt) processo para teste em pequena escala de catalisadores fcc.
DE60108721D1 (de) Schalldämpfender Aufbau für Eisenbahngleise
ATE312914T1 (de) Rdgb-proteine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition